OS Therapies
OSTX • XASE
OS Therapies is a pharmaceutical preparations company trading on XASE, led by CEO Paul A. Romness, with a market cap of $44.7M.
CEOPaul A. Romness
Next Earnings
Upcoming earnings announcement for OS Therapies
Date
Monday, March 30, 2026 (in 2 months)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q4 2025
EPS Estimate
-$0.16
Earnings History
Past 6 earnings reports for OS Therapies
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 17, 2025 | Q3 2025 | -$0.21Est: -$0.13 | -61.5% | -Est: $27.5M | -100.0% |  10-Q |
| Aug 18, 2025 | Q2 2025 | -$0.19Est: -$0.13 | -46.2% | - | — | 10-Q |
| May 16, 2025 | Q1 2025 | -$0.18Est: -$0.09 | -100.0% | - | — | 10-Q |
| Mar 31, 2025 | Q4 2024 | -$0.24Est: -$0.14 | -71.4% | - | — | 10-K |
| Nov 15, 2024 | Q3 2024 | -$0.18Est: -$0.12 | -50.0% | -Est: $150.0K | -100.0% | 10-Q |
| Aug 15, 2024 | Q2 2024 | -$0.26 | — | - | — | 10-Q |